Tissue-engineered skin substitutes

Bibliography

• COLLINS FS, PATRINOS A, JORDAN E, CHAKRAVARTI A, GESTELAND R, WALTERS L: New goals for the US Human Genome Project. Science (1998) 282:682–689.
   PubMed Web of Science ®Google Scholar
• PARENTEAU N, G NAUGHTON: Skin: the first tissue-engineered products. Sci. Am. (1999) April:83–85.
   Google Scholar
• •This is part of an excellent overview of the present state of tissue engineering
   Google Scholar
• HANSBROUGH J, DORE D, NOORDENBOS J,HANSBROUGH W: Dermagraft-TC as a biologic covering for partial-thickness burns. Burn Care Rehab. (1997):S104.
   Google Scholar
• STUTTAFORD T: Last-chance idea rescues a dying girl.The Times, 2nd July, (1997).
   Google Scholar
• DOLYNCHUK K, HILL P, GUENTHER L et al.: The role of Apligrarm in the treatment of venous leg ulcers. Ostomy/Wound Manag. (1999) 45:34–43.
   PubMedGoogle Scholar
• ••This is an excellent practical account of the use of Apligrafrm
   Google Scholar
• TRENT JF, KIRSNER RS: Tissue engineered skin: Apligraf, a bi-layered living skin equivalent.. Int. J. Clin. Pract. (1998) 52:408–413.
   PubMed Web of Science ®Google Scholar
• KIRSNER RS: The use of Apligraf in acute wounds. J. Dermatol. (1998) 25:805–811.
   PubMedGoogle Scholar
• Infant gets layer of bio-engineered skin. CNN Interac-tive (1999).
   Google Scholar
• MUHART M, MCFALLS S, KIRSNER R, KERDEL F,EAGLSTEIN WH: Bioengineered skin [letter]. Lancet (1997) 350:1142.
   PubMedGoogle Scholar
• EAGLSTEIN WH, ALVAREZ OM, AULETTA M et al.: Acute excisional wounds treated with a tissue-engineered skin (Apligra0. Dermatol. Surg. (1999) 25:195–201.
   PubMed Web of Science ®Google Scholar
• EISENBERG M, LLEWELYN D: Surgical management of hands in children with recessive dystrophic epider-molysis bullosa: use of allogeneic composite cultured skin grafts. Br. J. Plastic Surg. (1998) 51:608–613.
   PubMedGoogle Scholar
• EISENBERG M, LLEWELYN D: Effectiveness of Ortec's CCS treatment. Med. Industry Week (1998) 33 :16 .
   PubMedGoogle Scholar
• BLACK AF, BERTHOD F, L'HEUREUX N, GERMAIN L, AUGER : In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. Faseb. J. (1998) 12:1331–1340.
   PubMed Web of Science ®Google Scholar
• •Interesting new development in the field of tissue engineered skin substitutes.
   Google Scholar
• ROSE ML: Endothelial cells as antigen-presenting cells: role in human transplant rejection. Cell Mol Life Sci. (1998) 54:965–978.
   PubMed Web of Science ®Google Scholar
• VALYI-NAGY IT, MURPHY GF, MANCIANTI ML, WHITAKER D, HERLYN M: Phenotypes and interactions of human melanocytes and keratinocytes in an epidermal reconstruction model. Lab. Invest. (1990) 62:314–324.
   PubMed Web of Science ®Google Scholar
• TODD C, HEWITT SD, KEMPENAAR J, NOZ K, THODY AJ,PONEC M: Co-culture of human melanocytes and keratinocytes in a skin equivalent model: effect of ultraviolet radiation. Arch. Dermatol. Res. (1993) 285:455–459.
   PubMed Web of Science ®Google Scholar
• FRANSSON J, HEFFLER LC, TENGVALL UNDER M, SCHEYNIUS A: Culture of human epidermal Langer-hans cells in a skin equivalent. Br. J. Dermatol. (1998) 139:598–604.
   PubMed Web of Science ®Google Scholar
• KARLSSON JOM, TONER M: Long-term storage of tissuesby cryopreservation: critical issues. Biomaterials (1996) 17:243–256.
   PubMed Web of Science ®Google Scholar
• MULDREW K, HURTIG M, NOVAK K, SCHACHAR N, MCGANN LE: Localization of freezing injury in articular cartilage. Cryobiology (1994) 31:31–38.
   PubMed Web of Science ®Google Scholar
• BISCHOF J, HUNT CJ, RUBINSKY B, BURGESS A, PEGG DE:Effects of cooling rate and glycerol concentration on the structure of the frozen kidney: assessment by cryo-scanning electron microscopy. Cryobiology (1990) 27:301–310.
   PubMed Web of Science ®Google Scholar
• MAZUR P, COLE KW, SCHREUDERS PD, MAHOWALD AP:Contributions of cooling and warming rate and developmental stage to the survival of Drosophila embryos cooled to -205 degrees C. Cryobiology (1993) 30:45–73.
   PubMed Web of Science ®Google Scholar
• ALT J, SHELTON JN: Vitrification of preimplantationstages of mouse embryos. J. Reprod. Fertil. (1993) 98:459–465.
   PubMedGoogle Scholar
• MANSBRIDGE J, LIU K, PATCH R, SYMONS K, PINNEY E: Three-dimensional fibroblast culture implant for the treatment of diabetic foot ulcers: metabolic activity and therapeutic range. Tissue Eng. (1998) 4:403–414.
   PubMedGoogle Scholar
• GIACCIA AJ, AUGER EA, KOONG A, TERRIS DJ, MINCHINTON Al, HAHN GM, BROWN JM: Activation of the heat shock transcription factor by hypoxia in normal and tumor cell lines in vivo and in vitro. Int. J. Radiat. Oncol. Biol. Phys. (1992) 23:891–897.
   PubMed Web of Science ®Google Scholar
• MAYTIN EV: Heat shock proteins and molecular chaperones: implications for adaptive responses in the skin. J. Invest. Dermatol. (1995) 104:448–455.
   PubMed Web of Science ®Google Scholar
• MANSBRIDGE J, LIU K: Three-dimensional fibroblastcultures respond to cryopreservation with the induction of selective stress proteins. Cryobiology (1998) 37:409.
   Google Scholar
• LIU K, YANG Y, PINNEY E, MANSBRIDGE J: Cryopreser-vation of the three-dimensional fibroblast-derived tissue results in a stress response including induction of growth factors. Tissue Eng. (1998) 4:477.
   Google Scholar
• SHER AE, HULL BE, ROSEN S, CHURCH D, FRIEDMAN L, BELL E: Acceptance of allogeneic fibroblasts in skin equivalent transplants. Transplantation (1983) 36:552–557.
   PubMed Web of Science ®Google Scholar
• THIVOLET J, FAURE M, DEMIDEM A, MAUDUIT G: Long-term survival and immunological tolerance of human epidermal allografts produced in culture. Transplantation (1986) 42:274–280.
   PubMed Web of Science ®Google Scholar
• OTTO WR, NANCHAHAL J, LU QL, BODDY N, DOVER R: Survival of allogeneic cells in cultured organotypic skin grafts. Plast. Reconstr. Surg. (1995) 96:166–176.
   PubMed Web of Science ®Google Scholar
• BROWER V: Genentech enlightens other angiogenesis programs. Nature Biotechnol. (1999) 17:326–327.
   PubMed Web of Science ®Google Scholar
• ISNER JM: Vascular endothelial growth factor: gene therapy and therapeutic angiogenesis. Am. J. Cardiol (1998) 82:63S–64S.
   Google Scholar
• ISNER JM, BAUMGARTNER I, RAUH G et al.: Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J. Vasc. Surg. (1998) 28:964–973
   PubMed Web of Science ®Google Scholar
• ISNER JM, TAKAYUKI A: Therapeutic angiogenesis.Front. Biosci. (1998) 3:49–69.
   Google Scholar